文献速递主动脉疾病

衰弱指数、格拉斯哥动脉瘤评分与术中因素在择期腹主动脉瘤修复术后早期结局预测中的作用

Frailty, Glasgow Aneurysm Score, and Intraoperative Factors in Predicting Early Outcomes after Elective Abdominal Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2026-04-06

单中心队列纳入504例择期腹主动脉瘤修复患者,评估mFI-5、GAS及术前肺功能对早期结局的预测价值。30天死亡率低(1.4%),GAS与mFI-5均与死亡率无关;mFI-5与术后并发症相关(每增加1分OR≈1.34,P=0.023),但肾上钳夹/短颈解剖和术中失血是并发症及延长通气的最强独立预测因素。

要点

  • 择期AAA修复术后30天死亡率低(1.4%),GAS和mFI-5均不能预测死亡。
  • mFI-5每增加1分与术后并发症风险升高相关(OR≈1.34,P=0.023),仅作辅助评估工具。
  • 肾上钳夹或短颈解剖及术中失血是并发症和延长通气的最强独立预测因素。

核心结论

  • 在低围手术期死亡率的当代队列中,GAS对择期AAA修复术后早期结局预测价值有限。
  • mFI-5与术后并发症相关但与延长通气无关,应仅作为辅助风险评估工具。
  • 解剖和术中因素尤其是颈部解剖和失血仍是早期术后结局的主要决定因素。

研究设计与样本

  • 患者接受开放修复(OR;n=331)或血管内动脉瘤修复(EVAR;n=173)。
  • 评估五因子改良衰弱指数(mFI-5)、GAS和术前肺功能(FEV1/FVC比值)。
  • 主要结局为30天死亡率和术后并发症;次要结局包括延迟拔管。
  • 采用多变量逻辑回归和ROC分析,但死亡分析因事件少以描述性为主。

主要发现

  • 总体30天死亡率为1.4%(EVAR 1.2%,OR 1.5%),事件数少无法进行有意义的多变量分析。
  • GAS和mFI-5均与死亡率无关。
  • mFI-5较高与术后并发症增加相关(中位数=2;P=0.036),每增加1分并发症风险升高(OR≈1.34;P=0.023)。
  • GAS与术后并发症无关。
  • 肾上钳夹或短颈解剖及术中失血增加是并发症和延长通气的最强独立预测因素。

关键数值与推荐

  • mFI-5每增加1分与并发症风险升高相关(OR≈1.34;P=0.023)。
  • mFI-5与并发症相关(中位数=2;P=0.036)。
  • 30天死亡率1.4%(EVAR 1.2%,OR 1.5%)。

临床怎么用

  • GAS对择期AAA修复术后早期结局预测价值有限,不应单独用于风险分层。
  • mFI-5可作为辅助风险评估工具,但需结合解剖和术中因素综合判断。
  • 肾上钳夹或短颈解剖及术中失血是早期并发症和延长通气的主要决定因素,应重点关注。

局限性

  • 单中心回顾性队列设计可能限制普遍性。
  • 30天死亡率低(1.4%)导致死亡分析以描述性为主,无法识别可靠死亡预测因素。
  • mFI-5与并发症关联的具体机制未阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate preoperative risk stratification in patients undergoing elective abdominal aortic aneurysm (AAA) repair remains challenging. Traditional risk scores such as the Glasgow aneurysm score (GAS) rely primarily on static clinical variables and may inadequately reflect physiological reserve. Frailty indices and pulmonary function measures have emerged as potential adjuncts, but their predictive value in contemporary AAA populations is unclear. METHODS: We conducted a single-center cohort study including 504 patients undergoing elective AAA repair between November 2019 and December 2024. Patients were treated with open repair (OR; n = 331) or endovascular aneurysm repair (EVAR; n = 173). The five-factor modified frailty index (mFI-5), GAS, and preoperative pulmonary function (FEV1/FVC ratio) were assessed. Primary outcomes were 30-day mortality and postoperative morbidity; secondary outcomes included delayed extubation. Multivariable logistic regression and receiver operating characteristic analyses were performed; however, mortality analyses were primarily descriptive due to the low number of events. RESULTS: Overall, 30-day mortality was low (1.4%; EVAR 1.2%, OR 1.5%), precluding meaningful multivariable analysis and identification of reliable predictors of death. Neither GAS nor mFI-5 was associated with mortality. Higher mFI-5 was associated with increased postoperative morbidity despite identical median values between groups (median = 2; P = 0.036), with each one-point increase in mFI-5 associated with a higher risk of complications (OR ≈ 1.34; P = 0.023). GAS was not associated with postoperative complications. In contrast, suprarenal clamping or short neck anatomy and increased intraoperative blood loss were the strongest independent predictors of morbidity and prolonged ventilation. Preoperative FEV1/FVC ratio was not independently associated with postoperative complications or ventilation duration. CONCLUSION: In this contemporary cohort with low perioperative mortality, GAS demonstrated limited predictive value for early outcomes after elective AAA repair. The mFI-5 was associated with postoperative morbidity but not with prolonged ventilation and should be used only as an adjunctive risk assessment tool. Anatomical and intraoperative factors-particularly neck anatomy and blood loss-remain the principal determinants of early postoperative outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stehno O, Miskeje O, Sedivy P, et al. Frailty, Glasgow Aneurysm Score, and Intraoperative Factors in Predicting Early Outcomes after Elective Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2026. PMID: 41951204. doi:10.1016/j.avsg.2026.03.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。